Valeritas Holdings (VLRX)

Markets a disposable device that delivers basal-bolus insulin therapy for Type 2 diabetes.

Health Care - Health Care Equipment & Supplies

IPO Performance
Latest Trade ()
First Day Return
Return from IPO
 
Valeritas Holdings IPO News more
  • .
IPO Data
IPO File Date 02/06/2017
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $50
 
IPO Data
IPO Date
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $$50
 
Underwriters
more
Business Overview
We are a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. We designed our first commercialized product, the V-Go Wearable Insulin Delivery Device, or V-Go, to help patients with Type 2 diabetes who require insulin to achieve and maintain their target blood glucose goals. V-Go is indicated for continuous subcutaneous infusion of insulin over 24 hours and on-demand bolus dosing in two-unit increments in adult patients requiring insulin. V-Go is a small, discreet and easy-to-use disposable insulin delivery device that a patient adheres to his or her skin. V-Go is not considered durable medical equipment because it is not intended for repeated use. Each V-Go device is designed to be worn for 24 hours, removed from the body and disposed. V-Go enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery throughout the day and to manage their diabetes with insulin without the need to plan a daily routine around multiple daily injections.
We are a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. We designed our first commercialized product, the V-Go Wearable Insulin Delivery Device, or V-Go, to help patients with Type 2 diabetes who...
more
Company Data
Headquarters Bridgewater, NJ
Founded 2006
Employees 82
Website www.valeritas.com
 

Performance vs. IPO Index (IPOUSA)